4.7 Article

Usefulness of 11C-methionine-positron emission tomography for the diagnosis of progressive multifocal leukoencephalopathy

期刊

JOURNAL OF NEUROLOGY
卷 261, 期 12, 页码 2314-2318

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00415-014-7500-y

关键词

Progressive multifocal leukoencephalopathy; C-11-methionine-positron emission tomography; F-18-fluorodeoxyglucose-positron emission tomography; Mefloquine

资金

  1. Ministry of Health, Labor, and Welfare of Japan [H24-AIDS-Wakate-002]
  2. Research Committee of Prion Disease and Slow Virus Infection from the Ministry of Health, Labor, and Welfare of Japan [H23-Nanchi-Ippan-013]
  3. Grants-in-Aid for Scientific Research [24790341] Funding Source: KAKEN

向作者/读者索取更多资源

Progressive multifocal leukoencephalopathy (PML) is a subacute demyelinating disease of the brain caused by the JC virus that occurs mainly in immunocompromised patients. The prognosis is very poor. As the lesion looks like non- specific leukoencephalopathy, making a diagnosis at the early stage is very difficult. We report three PML cases in which there was a mismatch between C-11-methionine-positron emission tomography (MET-PET) uptake and F-18-fluorodeoxyglucose-positron emission tomography (FDG-PET) uptake. All three cases demonstrated the hyper-uptake of MET around the white matter lesions and hypo-uptake of FDG inside the lesions. We speculate that the infection had ended inside the white matter lesions of these patients, while JC virus infection was ongoing around the lesions, resulting in the increase of methionine metabolism, and the glucose metabolism was reduced or intermediate because inflammatory cells infiltrate PML lesions rarely. Two patients who were diagnosed and treated with mefloquine while the JC virus was at a low level in the cerebrospinal fluid are still alive. We suggest the usefulness of MET-PET for the early diagnosis of PML and early treatment with mefloquine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据